Trials / Unknown
UnknownNCT01075945
Dihydroartemisinin- Piperaquine Versus Artemether- Lumefantrine in the Treatment Uncomplicated Plasmodium Falciparum Malaria in Sudan
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 140 (estimated)
- Sponsor
- University of Khartoum · Academic / Other
- Sex
- All
- Age
- 5 Years – 95 Years
- Healthy volunteers
- Not accepted
Summary
Dihydroartemisinin- Piperaquine is not inferior to artemether-lumefantrine
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dihydroartemisinin- piperaquine | three tablets per day |
| DRUG | artemether- lumefantrine | twenty tablet in eight doses |
Timeline
- Start date
- 2010-02-01
- Primary completion
- 2010-04-01
- Completion
- 2010-04-01
- First posted
- 2010-02-25
- Last updated
- 2010-02-25
Locations
1 site across 1 country: Sudan
Source: ClinicalTrials.gov record NCT01075945. Inclusion in this directory is not an endorsement.